Acute Lymphoblastic Leukemia (ALL)

What We Offer

Acute lymphoblastic leukemia (ALL) is a cancer of the blood in which too many lymphocytes, a type of white blood cell, are produced by the bone marrow and by organs of the lymph system. Patients with leukemia are evaluated and treated in Stanford's Hematology and Bone Marrow Transplant clinics by a team of world-renowned doctors with advanced expertise in chemotherapy protocols for leukemia. Through active participation in the National Comprehensive Cancer Network (NCCN), our hematologists help develop the national guidelines for the management of hematologic malignancies. Our goal is to improve the survival and quality of life of patients.

Condition Spotlight

Robert Negrin, MD: Why I Went into Medicine Robert Negrin, MD: Why I Went into Medicine

Watch Video

Beverly Mitchell, MD: Why I Went into Medicine Beverly Mitchell, MD: Why I Went into Medicine

Watch Video

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Clinical Trials

Open Clinical Trials

View All

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Closed trials are not currently enrolling, but may open in the future.